EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease

Evgeny J Chumin, Charles P Burton, Rebecca Silvola, Ethan W Miner, Scott C Persohn, Mattia Veronese, Paul R Territo iD

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Evgeny J Chumin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Wellcome Trust, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD), the leading cause of dementia worldwide, represents a human and financial impact for which few effective drugs exist to treat the disease. Advances in molecular imaging have enabled assessment of cerebral glycolytic metabolism, and network modeling of brain region have linked to alterations in metabolic activity to AD stage. METHODS We performed 18 F‐FDG positron emission tomography (PET) imaging in 4‐, 6‐, and 12‐month‐old 5XFAD and littermate controls (WT) of both sexes and analyzed region data via brain metabolic covariance analysis. RESULTS The 5XFAD model mice showed age‐related changes in glucose uptake relative to WT mice. Analysis of community structure of covariance networks was different across age and sex, with a disruption of metabolic coupling in the 5XFAD model. DISCUSSION The current study replicates clinical AD findings and indicates that metabolic network covariance modeling provides a translational tool to assess disease progression in AD models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAnimalsFemaleMaleMiceAgingBrainFluorodeoxyglucose F18Metabolic Networks and PathwaysPositron-Emission Tomography

Stichwörter der Autor:innen

Alzheimer's diseaseconnectomicsmetabolic covariance networkspreclinical models

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Psychological and Brain Sciences, Indiana University, Bloomington, Indiana, USA.
  • Indiana University Network Science Institute, Indiana University, Bloomington, Indiana, USA.
  • Department of Medicine, Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Department of Information Engineering, University of Padua, Padua, Italy.

ORCID-Profile: Paul R Territo

Förderung

  • NIA NIH HHS
  • Wellcome Trust
  • National Institute on Aging

Zitieren

APA

Chumin, E. J., Burton, C. P., Silvola, R., Miner, E. W., Persohn, S. C., Veronese, M., & Territo, P. R. (2024). Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13538

Vancouver

Chumin EJ, Burton CP, Silvola R, Miner EW, Persohn SC, Veronese M, et al. Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13538

BibTeX
@article{Chumin2024,
  author = {Chumin, Evgeny J and Burton, Charles P and Silvola, Rebecca and Miner, Ethan W and Persohn, Scott C and Veronese, Mattia and Territo, Paul R},
  title = {Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13538}
}
Kostenlos starten →